We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
12 December 2018
It is well known that the law often struggles to keep up with new products and activities, particularly those based on technological developments. In many cases, the legal provisions which apply to regulated activities lose their applicability due to the speed with which technology enables parties to operate outside the scope of the law or the jurisdiction of the relevant authorities. This is particularly true for physical research involving living organisms, such as humans, as advancements in communication and the transfer of data have significantly broadened the scope of such research.
Research involving humans is heavily regulated in most countries due to the ethical implications and risks that it may pose for the individuals concerned. The Mexican General Health Law establishes that medical investigations and research are subject to sanitary regulation by the health authorities. Particular attention is given to activities that constitute investigations involving humans or clinical trials.
Under the law, 'medical investigations' include all kinds of action that contribute to the collective knowledge of:
The General Health Law Regulations in Health Investigation Matters establish that 'investigations involving humans' include all types of research involving pharmaceutical products, medical devices, medical processes and all other data collection relating to human health.
In addition to the above law and regulations, other provisions set out guidelines and criteria regarding clinical trials or medical investigations, including:
As a rule, the regulations establish that clinical trials (and, in general, clinical research and investigations) involving humans may only be carried out in a health institution.
A 'health institution' is a place:
The conditions that must be satisfied to determine whether the latter criterion is met include the existence of:
Thus, in order to carry out research and investigations regarding humans, parties must have:
These legal requirements and conditions apply only to activities carried out in the Mexican territory, as defined by the Constitution.
Notwithstanding the definition of medical investigations – including the relevant requirements and restrictions – the applicable provisions do not contemplate the possibility of obtaining, analysing, reviewing or performing diverse activities that constitute research and investigations involving humans through new technologies and platforms that do not require a physical presence, premise or place (ie, health institution) in Mexico.
Under the current provisions, it is questionable whether research and investigations which involve Mexican individuals located in Mexico (or data, facts, circumstances, evidence or any other information generated in Mexico), but which are undertaken by an individual or institution located abroad, are subject to the conditions and requirements to which health investigations (specifically clinical trials) are subject.
The use of new technological platforms through which data, images, test results, sounds and surveys, among other things, are transferred outside Mexico to be used in an investigation or research relating to human health falls outside the scope of the activities subject to sanitary regulation by the Mexican health authorities.
Under these new platforms, individuals and legal entities outside Mexico may collect data and information to develop, investigate, review, determine and increase their knowledge of, among other things:
Since these activities are not carried out in Mexico or at a place or premises in Mexico, the current statute regarding health investigations could be deemed to not apply. However, in some cases, the processes for obtaining such data could be subject to legal requirements regarding privacy, intellectual property, telecoms or other specific legal issues.
The excessive burden on and requirements for parties undertaking medical investigations in Mexico may result in a loss of traditional channels due to the existence and widespread use of new technological alternatives that may avoid the physical presence requirement and associated costs.
The regulation of medical investigations has fallen behind in light of the available technological tools. As such, the legislation should be amended to lesson the burdensome and complicated requirements imposed on parties and reflect the reality of today's technological advancements.
For further information on this topic please contact José Alberto Campos Vargas at Sanchez-DeVanny Eseverri SC by telephone (+52 55 5029 8500) or email (email@example.com). The Sanchez-DeVanny Eseverri SC website can be accessed at www.sanchezdevanny.com.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.